BRAIN Biotech AG
Research BRAIN Biotech AG (BNN) on Bullrun: market cap EUR 61.17M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBNN
- ExchangeXETRA
- CountryGermany
- SectorBasic Materials
- IndustrySpecialty Chemicals
- CurrencyEUR
- Market capEUR 61.17M
- Financial periodQ1 2026
- RevenueEUR 11.48M
- Net income-EUR 3.46M
- Free cash flow-EUR 335.00K
- Gross margin58.6%
Valuation Snapshot
latest market cap is EUR 61.17M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 48.83M | -EUR 10.62M | -EUR 9.56M | 59.0% | n/a | EUR 6.19M | EUR 8.53M | -EUR 728.00K |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-27 | EUR 61.17M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About BRAIN Biotech AG
BRAIN Biotech AG provides bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. The company operates through two segments: BRAINBiocatalysts and BRAINBioIncubator. The BRAINBiocatalysts segment develops, produces, and distributes specialty enzymes, microorganisms, and ingredients. The BRAINBioIncubator segment encompasses a pipeline of research-intensive development projects primarily for the life sciences industry.
Related stock research
Other Basic Materials stocks
Frequently asked questions
What is BRAIN Biotech AG's market cap?
BRAIN Biotech AG's market capitalization is EUR 61.17M.
What does BRAIN Biotech AG do?
BRAIN Biotech AG provides bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. The company operates through two segments: BRAINBiocatalysts and BRAINBioIncubator. The BRAINBiocatalysts segment develops, produces, and distributes specialty enzymes, microorganisms, and ingredients. The BRAINBioIncubator segment encompasses a pipeline of research-intensive development projects primarily for the life sciences industry.